ClinicalTrials.gg
TerminatedNCT05776901C-STRESSUpdated Sep 15, 2023Results posted

C-STRESS: A Mental Health App for College Students With Depression

An Early Phase 1 interventional study of C-STRESS in Depression, Anxiety and Stress, Psychological, sponsored by Benten Technologies, Inc.. Terminated at 1 site in United States. Open to participants aged 18 Years to 30 Years. Per ClinicalTrials.gov, last updated 2023-09-15.

Sponsored by Benten Technologies, Inc. · Early Phase 1, Interventional, and Device feasibility

How we know

Why this study was terminated
Grant termination without continuation.

From the registry’s dates

  • Registered 9 months after the study started (first participant enrolled May 2022, registered Feb 2023).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Early Phase 1
Study type
Interventional
Enrollment
3
Allocation
Not applicable
Ages
18 Years to 30 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 3,715 studies in Depression with a site in United States — 579 open to participants now, 716 under way, 29 of them phase 3. Depression · United States.

Enrollment
3,173rd of 3,322
3 · median 72
Started
2022
with 200 others
Phase 1
179 of 3,715
27 open now
Registered
2,974th of 3,715
by date

Among the 3,715 studies in Depression with a site in United States, this one is the 3,173rd largest by enrollment of the 3,322 interventional ones that give a count, is one of 201 that started in 2022, is one of 179 in phase 1, and was the 2,974th registered.

Depression

8,608 studies on the registry are indexed under Depression; 1,736 are open to participants now.

Browse Depression studies →

Open to participants now

579 of the 3,715 studies in Depression with a site in United States are open now. Recruiting first, the newest first:

574 more — sign in →

All 579 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 1,098 Depression studies recruiting now, 475 (43%) set no upper age limit and 522 (48%) stop at 75 or younger; 205 take children under 18; 315 take healthy volunteers.

This study: 18 Years to 30 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 3,715 studies in Depression with a site in United States, or all of them as a file.
02

Study summary

The goal of this pilot study is to examine the feasibility of the prototype C-STRESS app with 3 college students from UCI with clinically significant depression (scored ≥ 10 on the Patient Health Questionnaire-9). The main question it aims to answer is: whether the prototype C-STRESS is useful for college students to manage daily stress and depression symptoms.

Participants were asked to use the C-STRESS app daily for 6 weeks to participate in CBCT lessons, watch guided meditation videos, complete short reflective exercises, and engage with other content provided in C-STRESS (i.e., attending drop-in sessions, journaling, completing mood and wellbeing check-ins, and reading educational articles on depression, anxiety, and stress). At the end of week 3 and 6, participants completed 6 online surveys (System Usability Scale, Technology Acceptance Model, Patient Health Questionnaire-9, General Anxiety Disorder-7, Health Related Quality of Life-4, and Brief-COPE) to assess C-STRESS's usability/feasibility and changes in depressive symptoms and coping styles over the study period.

Read the detailed description

More than half of U.S. college students experience significant symptoms of depression, anxiety or stress, and three-fourths of these college students do not obtain professional help due to overburdened mental health services at universities and colleges. Prevalence of mental disorders and inadequate utilization of mental health services is a particularly severe problem for minority students and community college students. Cognitively Based Compassion Training (CBCT) has been administered to a variety of populations, including college students (undergraduate students, medical school students) and younger adolescents in prior completed studies, that collectively showed that CBCT can significantly strengthen cognitive resilience to stress and substantially reduce depressive symptoms, stress-associated systemic inflammation, improve emotional regulation (including impulse control) and mindfulness; increase compassion, and improve empathetic accuracy (measured by fMRI) - a critical skill that aims at cultivating relationships and connection to others. Currently, as a face-to-face program, CBCT certification at Emory takes 1 year to complete, and there are only 48 CBCT instructors. Due to the course duration, location, and time-intensive requirement for certification, CBCT has limited reach and scalability in its current instructional model despite growing demands.

The research team developed C-STRESS, a digital treatment intervention that leverages CBCT to improve the mental health of college students. C-STRESS adapts the traditional intervention modality (face-to-face) of CBCT in the form of micro-learning and provides personalization options including virtual companions and an animated visual cue of growing a garden to promote student engagement. Using co-design sessions with college students, the research team developed other features in C-STRESS to address the target population's needs when it comes to using a mobile app for mental health care, including an audiovisual library of guided meditation and resources, journaling, virtual drop-ins with CBCT instructors, mood and wellbeing tracking, and crisis helpline.

The research team recruited an independent convenience sample of 3 UCI undergraduate and graduate students to pilot test the initial content (introduction and modules 0-3) of the prototype C-STRESS mobile application. Participants completed measures via REDCap. Once enrolled, participants met with a member of the research team via Zoom to a) download the prototype app, b) complete app orientation (eg. indicate reason(s) for using the app, indicate color scheme \& frequency of notification preferences, select avatar if desired, etc.), c) begin to explore the app and its functionality with a research team member available to provide technical assistance, and d) complete the System Usability Scale and Technology Acceptance Model questionnaires via REDCap survey link. After the app orientation, participants were asked to use the prototype C-STRESS application at least once per day for 6 weeks. Daily usage ranged from approximately 2 minutes (opening the app and performing a one-minute meditation) to as much time as the participant desires (opening the app, completing available content, and unlimited meditation/reflection/journaling, etc. multiple times per day). At the end of week 3 (timepoint 1) and week 6 (timepoint 2), the participants were asked to complete measures via REDCap survey to assess C-STRESS's usability/feasibility and changes in depressive symptoms and coping styles over the 6-week study period.

03

Conditions studied

  • Depression
  • Anxiety
  • Stress, Psychological
  • Mobile Phone Use

Keywords

  • Depression
  • Anxiety
  • Stress
  • mHealth
  • college students
04

Who can participate

Ages eligible
18 Years to 30 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Undergraduate or graduate students
  • Enrolled at University of California Irvine (UCI)
  • Between the ages of 18-30
  • Speak and understand English
  • Have access to the internet for 6 weeks to participate in study activities via Zoom
  • Report depression (scores ≥ 10 on the Patient Health Questionnaire-9)
  • Have a smart phone with either iPhone Operating System (iOS) or android operating system

Exclusion criteria

Exclusion Criteria:

  • Report active suicidal ideation unless they obtain a written note of approval from a psychiatric provider
  • Female student who self-report pregnancy or plans to become pregnant within the next 3 months
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Clinically significant

Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.

05

Study design

Phase
Early Phase 1
Primary purpose
Device feasibility
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
3 participants (actual)

Interventions

  • DeviceC-STRESS

    Participants were asked to use the C-STRESS app daily for 6 weeks to participate in Cognitively Based Compassion Training (CBCT) lessons, watch guided meditation videos, complete short reflective exercises, and engage with other content provided in C-STRESS (i.e., attending drop-in sessions, journaling, completing mood and wellbeing check-ins, and reading educational articles on depression, anxiety, and stress)

06

What researchers measure

Primary outcomes

  1. Change From Baseline System Usability Scale Scores at Week 3 and Week 6

    The System Usability Scale (SUS) is a reliable assessment tool for evaluating the perceived usability and ease of use of a product or service. The scale comprises ten questions, each with five possible responses, ranging from 1 (Strongly disagree) to 5 (Strongly agree). The participant's response to each question is converted to a score, added together and then multiplied by 2.5 to convert their original responses to a score of 0-100. A higher score indicates higher perceived usability and ease of use of a product or service. SUS was assessed at both the baseline and week 3. However, there was no assessment of SUS in week 6 due to grant termination.

    Time frame: Baseline, week 3

07

Results

Posted Sep 15, 2023
Limitations and caveats
The enrollment of only 3 female participants compromised the generalizability of this study in two ways. Firstly, with such a small sample size, it is challenging to draw broad conclusions regarding the usability of the C-STRESS app for the boarder population. Secondly, having an imbalanced representation of gender can limit the ability to detect potential gender-specific effects or gender differences.

Participant flow

Participants were recruited via print, email, or electronic posting of flyer on UCI websites or affiliated social media and locations in and around UCI campus from March 16 to May 31, 2022. All three participants were enrolled on May 04, 2022. Due to grant termination, final collection of data for the primary outcome was on May 25, 2022, which allowed us to collect data at baseline and week 3, but not perform data collection at week 6 due to grant termination.

Participant flow — Overall Study
MilestoneC-STRESS
Started3
Week 33
Week 60
Completed0
Not completed3
Withdrew: Covid delays and grant termination without continuation.3

Outcome measures

PrimaryChange From Baseline System Usability Scale Scores at Week 3 and Week 6

The System Usability Scale (SUS) is a reliable assessment tool for evaluating the perceived usability and ease of use of a product or service. The scale comprises ten questions, each with five possible responses, ranging from 1 (Strongly disagree) to 5 (Strongly agree). The participant's response to each question is converted to a score, added together and then multiplied by 2.5 to convert their original responses to a score of 0-100. A higher score indicates higher perceived usability and ease of use of a product or service. SUS was assessed at both the baseline and week 3. However, there was no assessment of SUS in week 6 due to grant termination.

Time frame:
Baseline, week 3
Reported as:
Mean · score on a scale
Change From Baseline System Usability Scale Scores at Week 3 and Week 6
score on a scaleC-STRESS
Milestone 1 (week 1): Completion of the C-STRESS app orientation session and the SUS questionnaire71.67 ± 11.61
Milestone 2: Completion of the SUS questionnaire at week 337.5 ± 11.37
Change from baseline SUS scores at week 334.17 ± 20.45
Statistical analysis
  • C-STRESS · t-test, 2 sided · p = <0.05 · Mean diff in sus from baseline at week 3: 34.17 · 95% CI -28.04 to 96.37

Adverse events

Collected over Adverse event data for the entire study were collected over 27 days, starting from the enrollment of the first participant on May 04, 2022, to May 31, 2022. Adverse event data for each participant were collected twice over 3 weeks, at the baseline and 3-week follow-up.. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
C-STRESS0/3 (0%)0/3 (0%)0/3 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)C-STRESS
Mean24.67 ± 1.89
Sex: Female, Male
Sex: Female, Male(Participants)C-STRESS
Female3
Male0
Race (NIH/OMB)
Race (NIH/OMB)(Participants)C-STRESS
American Indian or Alaska Native0
Asian0
Native Hawaiian or Other Pacific Islander0
Black or African American1
White1
More than one race1
Unknown or Not Reported0
Region of Enrollment
Region of Enrollment(participants)C-STRESS
United States3
System Usability Scale
System Usability Scale(score on a scale)C-STRESS
Mean54.58 ± 20.59
08

Study locations

1 site
  • UCI
    Irvine, California 92697, United States
09

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from May 2022 to primary completion in May 2022, 0 months.

Results were first posted in Sep 2023, 1 year 3 months after primary completion.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 28, 2023
First posted
Mar 20, 2023
StartActual
May 4, 2022
Primary completionActual
May 25, 2022
CompletionActual
May 31, 2022
Results first posted
Sep 15, 2023
Last update
Sep 15, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 15, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT05776901
Lead sponsor
Benten Technologies, Inc.
Responsible party
Tony Ma (President, Benten Technologies, Inc.) — Principal investigator
First posted
Mar 20, 2023
Start date
May 4, 2022
Primary completion
May 25, 2022
Completion
May 31, 2022
Results posted
Sep 15, 2023
Last update
Sep 15, 2023

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Sep 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion